Therefore our current trial assessed participants for eligibility across two CAARMS assessments over 2-4 weeks.
Only one double-blind, placebo-controlled trial assessed the peroperative administration of t-PA on 100 patients [113].
The trial assessed development of the following "events": AIDS, serious non-AIDS related ailments, and death.
This randomized, double-blind, placebo-controlled trial assessed the efficacy, safety, and tolerability of asenapine in bipolar I disorder.
This trial assessed ODM-201's safety, pharmacokinetics, and activity in men with metastatic castration-resistant prostate cancer.
The moderate-to-high infection rates in the well-designed clones-in-families trial assessed here should provide a reasonably robust heritability estimate.
This trial assessed whether the new design reduced removal difficulties and had any effects on dislodgment, genital pain/discomfort, safety, and acceptability.
This masked, placebo-controlled trial assessed the efficacy and safety of venlafaxine and fluoxetine in depressed patients older than 65yearss.
This large, randomized controlled, multicentre pragmatic trial assessed the psychosocial effects of a combined diet-and-exercise lifestyle intervention targeting the obesogenic environment of SMI residential patients.
This multicenter phase III trial assessed survival of patients resuscitated with a hemoglobin-based oxygen carrier starting at the scene of injury.
This trial assessed the effect of tolvaptan on cognition, gait, and postural stability in adult patients with mild to moderate asymptomatic hyponatremia.
